Are the results of randomized controlled trials on anticoagulation in patients with atrial fibrillation generalizable to clinical practice?
about
Low adherence with antihypertensives in actual practice: the association with social participation--a multilevel analysisA randomized trial to assess the impact of an antithrombotic decision aid in patients with nonvalvular atrial fibrillation: the DAAFI trial protocol [ISRCTN14429643]Management of anticoagulant therapy for patients with prosthetic heart valves or atrial fibrillationFrequency and effect of optimal anticoagulation before onset of ischaemic stroke in patients with known atrial fibrillationPreference-based antithrombotic therapy in atrial fibrillation: implications for clinical decision makingThe safety and adequacy of antithrombotic therapy for atrial fibrillation: a regional cohort studyA cautionary note on data sources for evidence-based clinical decisions: warfarin and stroke preventionFrom Pharmacovigilance to Clinical Care OptimizationOutpatient management of oral vitamin K antagonist therapy: defining and measuring high-quality management.Coronary artery disease, left ventricular hypertrophy and diastolic dysfunction are associated with stroke in patients affected by persistent non-valvular atrial fibrillation: a case-control study.Stroke prevention and atrial fibrillation: reasons leading to an inappropriate management. Main results of the SAFE II study.Use of recombinant factor VIIa in patients with warfarin-associated intracranial hemorrhageCautionary tales in the clinical interpretation of therapeutic trial reports.Association between insufficient medication of antihypertensives and the severity of acute ischemic stroke.Cost-Effectiveness of Percutaneous Closure of the Left Atrial Appendage in Atrial Fibrillation Based on Results From PROTECT AF Versus PREVAIL.Practical issues with vitamin K antagonists: elevated INRs, low time-in-therapeutic range, and warfarin failure.Bleeding risk in atrial fibrillation patients taking vitamin K antagonists: systematic review and meta-analysis.Antithrombotic treatment in atrial fibrillation.The prestroke use of vitamin K antagonists for atrial fibrillation - trends over 15 years.Rapid bedside coagulometry prior to urgent neurosurgical procedures in anticoagulated patients.Outcome of coumarin-therapy in an outpatient setting over a 10-year period: coumarin-therapy in clinical practice.Perioperative management of patients on oral anticoagulants: a decision analysis.Stroke: secondary prevention.Are atrial fibrillation guidelines altering management? A community based study.Time in therapeutic range and stability over time for warfarin users in clinical practice: a retrospective cohort study using linked routinely collected health data in Alberta, Canada.Bleeding events and associated factors in a cohort of adult patients taking warfarin in Sarawak, Malaysia.Quality of management of oral anticoagulation as assessed by time in therapeutic INR range in elderly and younger patients with low mean years of formal education: a prospective cohort study.Atrial fibrillation or flutter and stroke: effectiveness of oral anticoagulation in clinical practice
P2860
Q24797246-6EB060A3-FE48-4EAA-B071-DAEBD94C59E0Q24803243-F3F6A244-492A-4149-9DFE-0E70FD7D195FQ28167261-64E57A35-7B37-4060-B43C-FC7FD22701B0Q28183704-C7063C5B-C2C5-45A6-8346-23F6EA8A3B32Q28191848-7AD2E362-D970-406B-BA41-BB4959111FADQ28200425-9493411F-C5AE-4C36-8AA7-B0C47247B8F0Q28218659-BFD31BC6-8932-4E6E-B1B4-D5CDBD7176FEQ28608160-7B025F6C-3FC4-4E60-9EF5-288E9A4BBF56Q33311569-4460039B-6364-475C-9A67-2D4FEFAC0C56Q35252790-7850A8EE-A274-442F-BC74-F943F8F5EE30Q35826197-AE5A4A5C-10D3-4C3F-B61D-7CCA62964E3FQ36256080-B5CA70C6-E196-4AAE-873B-FEE4F8EBF57DQ36278143-47076A2D-1C9B-4682-A005-3C52E159BD74Q36596072-CCB9598E-7F56-45FF-A72B-EE3FBB694486Q37015495-287982DD-600E-46FE-8488-ECCC310F177DQ37832976-69B0604A-8304-46A4-8DDB-A4FE244DCFB0Q38106617-4D41BFBE-A341-4095-B727-A7C7AA85A1E7Q41878910-DAF7A032-1E46-4129-865E-EFC3A9A80967Q43533823-BB8116B3-62DC-44E8-8004-0589BEA4257FQ44380447-F5AB9D66-A890-4341-8E8F-EB5526516ECEQ45119524-3DEFA829-A714-4D8E-A68F-A8A2F299D3D5Q46630338-C6C4D392-6FBF-4761-8CCD-273F361A2993Q46722175-E8867F89-5B85-4AEC-A969-AD41BDB1F428Q46865870-F5D35E29-B54B-4145-A2A7-DC096187634BQ47703734-DBC61709-B074-4E85-BF4B-BF19F897471BQ53099910-8DB7D5EF-1CAA-4ADB-A8DD-D0B45E85E9FFQ53156822-991CEE86-C67C-48CE-AB37-F6E2B2A751AFQ58854949-2C586FE5-5B28-4AD0-A00E-1587B89F1BC6
P2860
Are the results of randomized controlled trials on anticoagulation in patients with atrial fibrillation generalizable to clinical practice?
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Are the results of randomized ...... alizable to clinical practice?
@ast
Are the results of randomized ...... alizable to clinical practice?
@en
Are the results of randomized ...... alizable to clinical practice?
@nl
type
label
Are the results of randomized ...... alizable to clinical practice?
@ast
Are the results of randomized ...... alizable to clinical practice?
@en
Are the results of randomized ...... alizable to clinical practice?
@nl
prefLabel
Are the results of randomized ...... alizable to clinical practice?
@ast
Are the results of randomized ...... alizable to clinical practice?
@en
Are the results of randomized ...... alizable to clinical practice?
@nl
P921
P1476
Are the results of randomized ...... alizable to clinical practice?
@en
P304
P356
10.1001/ARCHINTE.161.11.1443
P407
P577
2001-06-01T00:00:00Z